Catarina Bernardo - Epidemiology

Author Information

Catarina Bernardo is affiliated with the National Cancer Registry and Epidemiology Research Unit at the Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, located in Lisboa, Portugal. Her work mainly focuses on the study of epidemiology and public health, with a specific interest in cancer research and the safe prescribing of medications in vulnerable populations.

Research Contributions

Catarina Bernardo has made significant contributions to the field of epidemiology. Her research includes a population-based cohort study on the effectiveness of palbociclib plus fulvestrant in treating advanced breast cancer, an epidemiological and clinical characterization of cutaneous malignant melanoma in Southern Portugal, and studies focused on drug-drug interactions and safe prescribing practices, particularly in elderly patients with dementia and those in nursing homes. Her work is pivotal in understanding and improving treatment protocols and quality of life for patients suffering from various chronic conditions, including mental health disorders and cancer.

Aliases

Catarina Bernardo is also known by the alias C. Bernardo in her publications.

Publication and Citation Metrics

Metric	Value
Number of Papers	9
Citation Count	12
H-Index	2

Publications:

Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study

DOI: 10.1016/j.breast.2022.02.005

Year: 2022

Population-based Study of Cutaneous Malignant Melanoma in the South Region of Portugal: Epidemiological and Clinical Characterization (2016-2017)

DOI: 10.21203/rs.3.rs-723918/v1

Year: 2021

Management of clinical relevant drug-drug interactions with antipsychotics in nursing homes

DOI: 10.1080/07853890.2021.1896843

Year: 2021

Identification of a Set of Patient-Related Features to Foster Safe Prescribing of Specific Antipsychotics in the Elderly With Dementia

DOI: 10.3389/fpsyt.2020.604201

Year: 2020

Efficacy and Quality of Life in Patients with Schizophrenia and Schizoaffective Disorders Treated with Long-acting Paliperidone Palmitate: A Naturalistic Longitudinal Study

DOI: 10.1016/j.eurpsy.2017.02.108

Year: 2017

What are the methods to handle MNAR?

What is One Health?

Why is Centralization Important in Epidemiology?

How Common are B Vitamin Deficiencies?

Why is Socioeconomic Status Important?

How Do Epidemics Influence Public Spending and Economic Policy?

What are the Challenges of Data Access?

What is Disease Control and Prevention?

What are the Complications of ARF?

How are Pre-existing Conditions Assessed?

Partnered Content Networks

Relevant Topics